{"id":"statins-hmg-coa","safety":{"commonSideEffects":[{"rate":"1-5","effect":"Muscle pain or myalgia"},{"rate":"1-3","effect":"Elevated liver enzymes (transaminitis)"},{"rate":"<0.1","effect":"Rhabdomyolysis"},{"rate":"1-3","effect":"Headache"},{"rate":"1-3","effect":"Gastrointestinal upset"}]},"_chembl":{"chemblId":"CHEMBL1794644","moleculeType":"Small molecule","molecularWeight":"911.67"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"HMG-CoA reductase converts HMG-CoA to mevalonate, a critical early step in the cholesterol biosynthetic pathway. By competitively inhibiting this enzyme, statins decrease hepatic cholesterol production, which triggers upregulation of LDL receptors on liver cells and increases clearance of LDL cholesterol from the bloodstream. This leads to reduced circulating LDL levels and has pleiotropic anti-inflammatory and endothelial protective effects.","oneSentence":"Statins inhibit HMG-CoA reductase, the enzyme that catalyzes the rate-limiting step in cholesterol synthesis, thereby reducing LDL cholesterol levels.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:09:40.754Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Primary prevention of cardiovascular disease in high-risk patients"},{"name":"Secondary prevention of cardiovascular events in patients with established coronary artery disease"},{"name":"Hypercholesterolemia"},{"name":"Dyslipidemia"}]},"trialDetails":[{"nctId":"NCT04067297","phase":"NA","title":"Using Big Data to Conduct Innovative Cardiovascular Clinical Trials","status":"ACTIVE_NOT_RECRUITING","sponsor":"Institute for Clinical Evaluative Sciences","startDate":"2019-10-01","conditions":"Cardiovascular Diseases, Cardiovascular Risk Factor, Dyslipidemias","enrollment":500000},{"nctId":"NCT07089589","phase":"","title":"Preoperative Statin Use and Major Adverse Cardiovascular Events in Liver Transplant Recipients","status":"COMPLETED","sponsor":"Asan Medical Center","startDate":"2008-01-02","conditions":"Major Adverse Cardiovascular Events, Liver Transplantation","enrollment":6871},{"nctId":"NCT07493603","phase":"PHASE1, PHASE2","title":"A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease","status":"RECRUITING","sponsor":"Xia Liang","startDate":"2026-01-16","conditions":"Coronary Heart Disease, Coronary Artery Disease, Atheroscleroses","enrollment":30},{"nctId":"NCT07392541","phase":"PHASE1, PHASE2","title":"Adebrelimab Combined With Gemcitabine, Cisplatin, and Simvastatin for Advanced Biliary Tract Cancer","status":"RECRUITING","sponsor":"Tongji Hospital","startDate":"2026-01-30","conditions":"Advanced Biliary Tract Carcinoma","enrollment":29},{"nctId":"NCT07478328","phase":"PHASE2","title":"Chaigui Longmu Ejiao Paste for Ischemic Heart Disease","status":"NOT_YET_RECRUITING","sponsor":"Longhua Hospital","startDate":"2026-03-08","conditions":"Ischemic Heart Disease","enrollment":60},{"nctId":"NCT07045142","phase":"PHASE3","title":"Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia Patients","status":"RECRUITING","sponsor":"Central South University","startDate":"2025-07-01","conditions":"Schizophrenia","enrollment":400},{"nctId":"NCT07460960","phase":"PHASE2","title":"TRIal of STatin Therapy Effect on Androgen Status and Erectile functioN in Men","status":"RECRUITING","sponsor":"Lomonosov Moscow State University Medical Research and Educational Center","startDate":"2026-03-05","conditions":"Erectile Dysfunction Due to Arterial Disease, Atheroscleroses, Erectile Disfunction","enrollment":150},{"nctId":"NCT06062394","phase":"NA","title":"Penn Medicine Healthy Heart","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2024-03-11","conditions":"Hypertension, Hyperlipidemias","enrollment":1980},{"nctId":"NCT07459972","phase":"PHASE4","title":"Clinical Evaluation of Simcyp-Guided Simvastatin Dosing in Patients With Liver Cirrhosis","status":"COMPLETED","sponsor":"Kafrelsheikh University","startDate":"2024-03-15","conditions":"Liver Cirrhosis, Portal Hypertension Related to Cirrhosis","enrollment":22},{"nctId":"NCT07359105","phase":"NA","title":"Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study)","status":"RECRUITING","sponsor":"Sin Gon Kim","startDate":"2026-03-09","conditions":"Dyslipidemia Associated With Type II Diabetes Mellitus","enrollment":2186},{"nctId":"NCT07462715","phase":"PHASE4","title":"Statins Against Bushfire Smoke","status":"NOT_YET_RECRUITING","sponsor":"Menzies Institute for Medical Research","startDate":"2026-05-01","conditions":"Healthy Adults","enrollment":100},{"nctId":"NCT06975111","phase":"PHASE2, PHASE3","title":"Focusing on the Menopausal Transition to Improve Mid-Life Women's Health","status":"NOT_YET_RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2026-03-01","conditions":"Menopause, Menopause Hot Flashes, Menopause Related Conditions","enrollment":200},{"nctId":"NCT07447206","phase":"PHASE2","title":"Vascular Intervention Strategies Trial for Alzheimer's","status":"NOT_YET_RECRUITING","sponsor":"University of Southern California","startDate":"2026-03","conditions":"Hypertension, Hypercholesterolemia, Dementia Risk Factors","enrollment":10},{"nctId":"NCT03269058","phase":"PHASE4","title":"Evaluate the Effects of Dapagliflozin in Patients With Type 2 Diabetes","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2017-12-20","conditions":"Type-2 Diabetes, Oral Antidiabetics","enrollment":28},{"nctId":"NCT07447648","phase":"","title":"Assessing the Impact of Intensification of Lipid Lowering Therapy With Guidelines-based Evinacumab Administration on Coronary Plaque Volumes Measured by Coronary Computed Tomography Angiography (CCTA) in Patients With Homozygous Familial Hypercholesterolemia (HoFH)","status":"NOT_YET_RECRUITING","sponsor":"Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi)","startDate":"2026-03","conditions":"Homozygous Familial Hypercholesterolemia (HoFH), Coronary Computed Tomography Angiography","enrollment":52},{"nctId":"NCT07445581","phase":"NA","title":"Tanhuo Decoction for Acute Coronary Syndrome With Cerebral Atherosclerosis in Elderly Patients","status":"NOT_YET_RECRUITING","sponsor":"Jinggang Xia, MD","startDate":"2026-02-28","conditions":"Acute Coronary Syndrome Comorbid With Cerebral Atherosclerosis","enrollment":480},{"nctId":"NCT07217938","phase":"PHASE2","title":"Novel Treatment of Radiation Associated Dysphagia With Statins","status":"RECRUITING","sponsor":"Peter MacCallum Cancer Centre, Australia","startDate":"2025-12-05","conditions":"Radiation-associated Dysphagia, Head &Amp; Neck Cancer","enrollment":48},{"nctId":"NCT04098003","phase":"PHASE4","title":"Investigation of the Gut Microbiome and Statin Response","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sony Tuteja","startDate":"2020-02-06","conditions":"Healthy Volunteers","enrollment":62},{"nctId":"NCT06696820","phase":"PHASE2, PHASE3","title":"Efficacy and Safety of Early Combined Therapy With PCSK9 Inhibitors and Statins in Acute Ischemic Stroke","status":"RECRUITING","sponsor":"Xiang Luo","startDate":"2024-11-29","conditions":"Acute Ischemic Stroke","enrollment":429},{"nctId":"NCT06488105","phase":"PHASE2","title":"Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2024-08-05","conditions":"Lipid Disorder, Hypercholesterolemia, Cardiovascular Diseases","enrollment":130},{"nctId":"NCT06538649","phase":"EARLY_PHASE1","title":"Effect of Statins on Crohn's Disease","status":"RECRUITING","sponsor":"Stanford University","startDate":"2024-12-12","conditions":"Crohn's Ileocolitis, Crohn Disease","enrollment":20},{"nctId":"NCT06841536","phase":"NA","title":"Combined Effects of Statins and Exercise on Training Sensitive Health Markers","status":"COMPLETED","sponsor":"University of the Faroe Islands","startDate":"2025-05-01","conditions":"Dyslipidemias","enrollment":120},{"nctId":"NCT06764966","phase":"PHASE2","title":"Statin and Beta Blocker Use in Patients With Decompensated Cirrhosis","status":"RECRUITING","sponsor":"CAMC Health System","startDate":"2025-09-09","conditions":"Decompensated Liver Cirrhosis, Cirrhosis, Decompensated Cirrhosis of Liver","enrollment":50},{"nctId":"NCT07098975","phase":"PHASE2","title":"Statin Intervention for Severe Early-Onset Placental Insufficiency. (STATIN-PRE Trial)","status":"RECRUITING","sponsor":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","startDate":"2026-01-14","conditions":"Preeclampsia (PE), Intrauterine Growth Restriction (IUGR), Placental Insufficiency","enrollment":154},{"nctId":"NCT07282756","phase":"NA","title":"Evaluation Of The Efficacy Of Subgingival Application Of Lovastatin Gel As An Adjunct To Non-Surgical Treatment Of Periodontitis In Generally Healthy Smokers And Non-Smokers Patients in Central Europe.","status":"RECRUITING","sponsor":"Medical University of Silesia","startDate":"2025-07-11","conditions":"Periodontal Diseases, Periodontitis, Periodontal Disease","enrollment":44},{"nctId":"NCT04975594","phase":"","title":"Statin-Intolerance Registry","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Leipzig","startDate":"2021-08-01","conditions":"Dyslipidemias","enrollment":1000},{"nctId":"NCT05289063","phase":"PHASE1","title":"Vascular Endothelial Dysfunction in Sleep Apnea","status":"RECRUITING","sponsor":"Columbia University","startDate":"2022-10-03","conditions":"Obstructive Sleep Apnea of Adult","enrollment":110},{"nctId":"NCT07404553","phase":"PHASE2, PHASE3","title":"A Study Of SHR-1918 In Participants With Hypercholesterolemia With Inadequate Lipid Control on Statins Plus PCSK9 Inhibitors","status":"NOT_YET_RECRUITING","sponsor":"Beijing Suncadia Pharmaceuticals Co., Ltd","startDate":"2026-03","conditions":"Hypercholesterolemia","enrollment":126},{"nctId":"NCT06863545","phase":"NA","title":"Further Lipid-Lowering With PCSK9 Inhibitors for Cardiovascular Outcomes in High-Risk Coronary Plaques Assessed by CT Angiography","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-04-22","conditions":"Coronary Artery Disease, CT Angiography, PCSK9","enrollment":3596},{"nctId":"NCT07391267","phase":"NA","title":"Pathogenesis of Chronic Kidney Disease Associated With Metabolic Dysfunction- Associated Fatty Liver Disease (MAFLD) and Treatment Response of Oral Semaglutide.","status":"NOT_YET_RECRUITING","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2026-02-01","conditions":"Chronic Kidney Diseases, MAFLD","enrollment":90},{"nctId":"NCT07389304","phase":"PHASE1","title":"[Effects of Selected Statins on Cardiovascular Parameters in Healthy Volunteers]","status":"NOT_YET_RECRUITING","sponsor":"Shaheed Benazir Bhutto University Sheringal Dir Upper","startDate":"2026-03-01","conditions":"Lipid Profile,Blood Pressure","enrollment":100},{"nctId":"NCT04404166","phase":"PHASE3","title":"Phone-based Intervention Under Nurse Guidance After Stroke 2","status":"COMPLETED","sponsor":"Northern California Institute of Research and Education","startDate":"2020-10-23","conditions":"Blood Pressure, Stroke, Cardiovascular Diseases","enrollment":500},{"nctId":"NCT03856632","phase":"PHASE4","title":"Liraglutide Effect in Atrial Fibrillation","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Miami","startDate":"2019-03-18","conditions":"Atrial Fibrillation","enrollment":60},{"nctId":"NCT07378293","phase":"PHASE1","title":"Effects of Selected Statins on Blood Glucose Levels in Healthy Volunteers","status":"NOT_YET_RECRUITING","sponsor":"Shaheed Benazir Bhutto University Sheringal Dir Upper","startDate":"2026-03-01","conditions":"Diabete Mellitus, Lipid Profile","enrollment":100},{"nctId":"NCT07208006","phase":"NA","title":"Very Early PCSK9 Inhibition for Acute Myocardial Infarction","status":"RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2026-01-01","conditions":"Acute Myocardial Infarction (AMI)","enrollment":1518},{"nctId":"NCT07084051","phase":"NA","title":"Improve Medication Adherence Among Stroke Survivors in Rural Kentucky","status":"COMPLETED","sponsor":"Hend Mansoor","startDate":"2025-07-24","conditions":"Stroke (CVA) or Transient Ischemic Attack","enrollment":4},{"nctId":"NCT07303699","phase":"PHASE2","title":"ATORvastatin in Pulmonary TUBerculosis: a POPulation PharmacoKinetics -PharmacoDynamics Sub-study (ATORTUB popPK-PD)","status":"RECRUITING","sponsor":"Obafemi Awolowo University Teaching Hospital","startDate":"2026-01-03","conditions":"Pulmonary Tuberculosis (TB)","enrollment":80},{"nctId":"NCT07032389","phase":"PHASE2","title":"A Polypill for Acute Coronary Syndrome","status":"RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2025-12-05","conditions":"Acute Coronary Syndrome","enrollment":1000},{"nctId":"NCT04679376","phase":"PHASE2","title":"Statins for the Treatment of NASH","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mayo Clinic","startDate":"2023-01-25","conditions":"NASH - Nonalcoholic Steatohepatitis","enrollment":70},{"nctId":"NCT06553157","phase":"PHASE1, PHASE2","title":"Statins Effect on Incidence of Side Effects of Platinum Based Chemotherapy","status":"COMPLETED","sponsor":"Minia University","startDate":"2024-09-01","conditions":"Solid Tumors, Ototoxicity","enrollment":56},{"nctId":"NCT04319627","phase":"PHASE3","title":"Statins for Venous Event Reduction in Patients With Venous Thromboembolism","status":"RECRUITING","sponsor":"Ottawa Hospital Research Institute","startDate":"2021-02-10","conditions":"Venous Thromboembolism, Blood Clot, Post Thrombotic Syndrome","enrollment":2700},{"nctId":"NCT07344610","phase":"","title":"Effects of Short-term Intensive Statin Therapy on Lipid Levels","status":"RECRUITING","sponsor":"General Hospital of Shenyang Military Region","startDate":"2026-01-08","conditions":"Ischemic Stroke","enrollment":800},{"nctId":"NCT06024096","phase":"PHASE4","title":"Systems Biological Assessment of Statin Effect on Vaccine Responses","status":"COMPLETED","sponsor":"Emory University","startDate":"2023-09-20","conditions":"Vaccine Response","enrollment":63},{"nctId":"NCT06782243","phase":"NA","title":"Comparison of High and Moderate Intensity Statins in Achieving the Target LDL-C Level After Acute Coronary Syndrome","status":"COMPLETED","sponsor":"Khyber Medical University Peshawar","startDate":"2024-12-20","conditions":"Acute Coronary Syndrome","enrollment":190},{"nctId":"NCT04765657","phase":"PHASE3","title":"Study of Efficacy and Safety of Inclisiran in Asian Participants With Atherosclerotic Cardiovascular Disease (ASCVD) or ASCVD High Risk and Elevated Low Density Lipoprotein Cholesterol (LDL-C)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2021-03-01","conditions":"Hypercholesterolemia","enrollment":345},{"nctId":"NCT07307989","phase":"PHASE2","title":"Early Statin-Ezetimibe Combination vs. Statin Monotherapy in Stroke With Atherosclerosis","status":"RECRUITING","sponsor":"Chang Gung Memorial Hospital","startDate":"2025-08-01","conditions":"Ischemic Stroke, Hypercholesteremia","enrollment":300},{"nctId":"NCT05641753","phase":"PHASE4","title":"Cholesterol Lowering and Residual Risk in Diabetes, Type 1","status":"RECRUITING","sponsor":"NYU Langone Health","startDate":"2022-12-06","conditions":"Type 1 Diabetes","enrollment":125},{"nctId":"NCT07303816","phase":"PHASE4","title":"Statins to Prevent Cancer Associated Blood Clots","status":"NOT_YET_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2026-04-01","conditions":"Venous Thromboembolism, Cancer, Cardiovascular Events","enrollment":4000},{"nctId":"NCT07286110","phase":"PHASE1","title":"Chinese Herbal Therapy (Qiqi Shengmai Formula) for Moyamoya Vasculopathy: The CHIMES Trial","status":"NOT_YET_RECRUITING","sponsor":"Fudan University","startDate":"2025-12-30","conditions":"Moyamoya Disease, Moyamoya Syndrome","enrollment":66},{"nctId":"NCT05764057","phase":"PHASE3","title":"DAPAgliflozine to Attenuate Cardiac RemOdeling afTEr aCuTe myOcardial Infarction","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-06-12","conditions":"AMI, STEMI, NSTEMI","enrollment":450},{"nctId":"NCT05537064","phase":"NA","title":"Centralized Prescribing for Statins","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Pennsylvania","startDate":"2022-11-02","conditions":"Hyperlipidemias","enrollment":1950},{"nctId":"NCT07012629","phase":"PHASE3","title":"A EUROpean Randomized Study on Blood-thinners and Cholesterol-lowering Treatments to Prevent Future Vascular Events in People With Covert Brain Infarcts (CBI)","status":"RECRUITING","sponsor":"Aarhus University Hospital","startDate":"2025-11-26","conditions":"Covert Brain Infarction","enrollment":1652},{"nctId":"NCT06897566","phase":"","title":"Barriers to Optimal LDL-C Targets in Patients With Atherosclerotic Cardiovascular Disease","status":"COMPLETED","sponsor":"Cairo University","startDate":"2024-09-21","conditions":"Coronary Artery Disease, Statin Adverse Reaction, LDL Level","enrollment":1000},{"nctId":"NCT07255820","phase":"PHASE4","title":"Dual vs Triple Lipid-Lowering Therapy in Type 2 Diabetes Mellitus Patients With Elevated LDL Cholesterol","status":"NOT_YET_RECRUITING","sponsor":"Bahria University","startDate":"2026-01-01","conditions":"Type 2 Diabetes Mellitus, Hypercholesterolemia / Elevated LDL Cholesterol","enrollment":126},{"nctId":"NCT07256171","phase":"","title":"COAST Study - Cholesterol Optimization After Stroke","status":"NOT_YET_RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2026-01-01","conditions":"Stroke (CVA) or Transient Ischemic Attack, Cerebral Hemorrhage","enrollment":500},{"nctId":"NCT05910476","phase":"PHASE4","title":"Comparative Study of Rosuvastatin/Ezetimib 20/10 mg and Atovastatin/Ezetimib 40/10 mg (TOLERANT Trial)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Yonsei University","startDate":"2023-05-03","conditions":"Coronary Artery Disease, Dyslipidemias","enrollment":200},{"nctId":"NCT07110415","phase":"PHASE4","title":"Efficacy and Safety Trials of Yangxinshi Tablets in the Treatment of Patients With Coronary Heart Disease Complicated by Cardiac Dysfunction","status":"RECRUITING","sponsor":"SPH Qingdao Growful Pharmacetical Co.,Ltd","startDate":"2025-11-06","conditions":"Coronary Heart Disease, Cardiac Dysfunction","enrollment":2708},{"nctId":"NCT04883840","phase":"PHASE2, PHASE3","title":"Drug Repurposing - Statins as Microbiota Modulating Agents in Ulcerative Colitis","status":"TERMINATED","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2020-10-22","conditions":"Ulcerative Colitis","enrollment":177},{"nctId":"NCT07239414","phase":"PHASE3","title":"Bempedoic Acid Versus Statins in Primary-Prevention Patients With Suboptimal Statin Adherence: Effects on LDL-C Reduction and Tolerability","status":"NOT_YET_RECRUITING","sponsor":"Sohaib Ashraf","startDate":"2025-11-10","conditions":"Cardiovascular","enrollment":690},{"nctId":"NCT04980716","phase":"PHASE3","title":"Early Specialized Cardiovascular Intervention Based on Impedance Cardiography in Locally Advanced Non-small Cell Lung Cancer Patients","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2021-06-01","conditions":"Non-small Cell Lung Cancer, Cardiovascular Complication","enrollment":524},{"nctId":"NCT05559164","phase":"PHASE2","title":"Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted","status":"RECRUITING","sponsor":"Rutgers, The State University of New Jersey","startDate":"2022-09-19","conditions":"Cardiac Toxicity, Early-stage Breast Cancer","enrollment":60},{"nctId":"NCT04262206","phase":"PHASE4","title":"Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults","status":"RECRUITING","sponsor":"Duke University","startDate":"2020-09-01","conditions":"Cognitive Impairment, Mild, Dementia, Cardiovascular Diseases","enrollment":20000},{"nctId":"NCT05300737","phase":"","title":"Symptomatic Carotid Outcomes Registry","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2022-08-01","conditions":"Carotid Stenosis, Ischemic Stroke, Transient Ischemic Attack","enrollment":114},{"nctId":"NCT07214857","phase":"","title":"Potential Eligibility and Estimated Preventable Cardiovascular Disease Events From Inclisiran Treatment in the United States","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2024-03-29","conditions":"Cardiovascular Disease","enrollment":1385},{"nctId":"NCT06423365","phase":"NA","title":"A Tool to Help Patients With Muscle Symptoms After Taking a Statin Medication.","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Utah","startDate":"2024-10-24","conditions":"Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hypercholesterolemia, Cardiovascular Diseases","enrollment":816},{"nctId":"NCT05720156","phase":"","title":"Immunomodulatory Effects of PCSK9 Inhibition","status":"WITHDRAWN","sponsor":"Massachusetts General Hospital","startDate":"2024-04-04","conditions":"Atherosclerotic Cardiovascular Disease, Cardiovascular Diseases, Atherosclerosis","enrollment":""},{"nctId":"NCT06199921","phase":"PHASE2","title":"ATORvastatin in Pulmonary TUBerculosis","status":"RECRUITING","sponsor":"Obafemi Awolowo University Teaching Hospital","startDate":"2024-01-03","conditions":"Pulmonary Tuberculosis, Tuberculosis, Koch's Disease","enrollment":440},{"nctId":"NCT03936361","phase":"PHASE3","title":"Statins In Intracerbral Hemorrhage","status":"RECRUITING","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2020-06-10","conditions":"Intracerebral Hemorrhage","enrollment":1456},{"nctId":"NCT07180745","phase":"PHASE4","title":"Empagliflozin Versus Statins in Non-Alcoholic Fatty Liver Disease","status":"NOT_YET_RECRUITING","sponsor":"Badr University","startDate":"2025-11-01","conditions":"Non-alcoholic Fatty Liver Disease NAFLD, Non-alcoholic Steatohepatitis NASH","enrollment":400},{"nctId":"NCT06702436","phase":"","title":"Invasive vs. Conservative Management in Cancer Patients With Non-ST Elevation MI (CAN-NSTEMI)\"","status":"COMPLETED","sponsor":"Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital","startDate":"2024-06-01","conditions":"Myocardial Infarction","enrollment":12500},{"nctId":"NCT07094412","phase":"NA","title":"Patient-engaged Development and Testing of Educational Content on Side Effects of Statins","status":"ENROLLING_BY_INVITATION","sponsor":"Weill Medical College of Cornell University","startDate":"2025-07-31","conditions":"Dyslipidemia","enrollment":30},{"nctId":"NCT06767345","phase":"PHASE4","title":"Comparison of Moderate-Intensity Statin Plus Ezetimibe vs. High-Intensity Statin for Coronary Plaque Stabilization","status":"RECRUITING","sponsor":"Korea University Anam Hospital","startDate":"2025-05-12","conditions":"Coronary Artery Disease, Atherosclerosis of Coronary Artery, Plaque, Atherosclerotic","enrollment":408},{"nctId":"NCT06520891","phase":"","title":"\"The Effect of The Combination Therapy of Statin and SGLT2i in The Treatment of Ischemic Heart Disease\"","status":"RECRUITING","sponsor":"Fayoum University","startDate":"2024-06-01","conditions":"2 Drugs Are Statin and SGLT2i","enrollment":90},{"nctId":"NCT02958852","phase":"PHASE2","title":"A Clinical Trial to Compare Efficacy and Tolerability of Atorvastatin in Addition to Endocrine Treatment With Focus on Mechanisms of Resistance to Endocrine Treatment (Fulvestrant/Aromatase Inhibitors) in Patients With Advanced Breast Cancer","status":"COMPLETED","sponsor":"Lund University Hospital","startDate":"2025-01-02","conditions":"Breast Cancer","enrollment":126},{"nctId":"NCT07148037","phase":"","title":"Effect of SLC01B1 (rs4149956) Polymorphism on the Efficacy and Tolerability of Atorvastatin in Pakistani Population","status":"COMPLETED","sponsor":"Riphah International University","startDate":"2024-09-01","conditions":"Hyperlipidemias","enrollment":150},{"nctId":"NCT05180942","phase":"","title":"Statins and prOgression of Coronary atheRosclerosis in melanomA Patients Treated With chEckpoint inhibitorS","status":"RECRUITING","sponsor":"Monash University","startDate":"2022-11-07","conditions":"Melanoma, Atherosclerosis","enrollment":130},{"nctId":"NCT02603328","phase":"PHASE1, PHASE2","title":"Atorvastatin Treatment of Cavernous Angiomas With Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2018-07-17","conditions":"Cerebral Cavernous Malformation","enrollment":80},{"nctId":"NCT06698666","phase":"PHASE3","title":"Efficacy of Statins Among Major Depressive Disorder","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2022-10-01","conditions":"Major Depressive Disorder, MDD","enrollment":145},{"nctId":"NCT07124728","phase":"NA","title":"Syntrillo Telehealth Stroke Risk Reduction Study","status":"NOT_YET_RECRUITING","sponsor":"Syntrillo, Inc","startDate":"2025-08","conditions":"Hypertension, Hypertension (HTN), Stroke Prevention","enrollment":68},{"nctId":"NCT05444062","phase":"NA","title":"Quebec Lung Cancer Screening PLUS Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Nicole Ezer, MD, FRCPC, MPH","startDate":"2023-04-23","conditions":"COPD, Coronary Artery Calcification","enrollment":330},{"nctId":"NCT05542147","phase":"NA","title":"Genetic-Dependent Cardiovascular Response to PPAR-Alpha Agonist Fenofibrate","status":"COMPLETED","sponsor":"Mario Luca Morieri","startDate":"2022-07-03","conditions":"Type 2 Diabetes, Cardiovascular Diseases, Pharmacogenomic Drug Interaction","enrollment":200},{"nctId":"NCT06090890","phase":"PHASE4","title":"Anti-inflammatory Therapy for Recurrent In-stent Restenosis","status":"RECRUITING","sponsor":"Fu Wai Hospital, Beijing, China","startDate":"2023-10-30","conditions":"In-stent Restenosis","enrollment":252},{"nctId":"NCT06551701","phase":"","title":"ACHIEVE Pilot Statins for Vascular Protection","status":"ACTIVE_NOT_RECRUITING","sponsor":"Duke University","startDate":"2025-05-19","conditions":"ASCVD","enrollment":225},{"nctId":"NCT07064135","phase":"NA","title":"Improved Medication and Care to Achieve Lipid Targets After Carotid Surgery","status":"NOT_YET_RECRUITING","sponsor":"Barmherzige Brüder Linz","startDate":"2025-08-04","conditions":"Dyslipidaemias, Carotid Artery Stenoses","enrollment":50},{"nctId":"NCT06902740","phase":"PHASE4","title":"PCSK9 Inhibitor With Statin Therapy for Asymptomatic Intracranial Atherosclerosis","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2025-09-01","conditions":"Intracranial Atherosclerosis, Intracranial Artery Stenosis, Atherosclerotic Plaque","enrollment":300},{"nctId":"NCT06858332","phase":"","title":"Lipoprotein(a) Levels in Patients With Atherosclerotic Cardiovascular Diseases in Russia","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2025-04-15","conditions":"Atherosclerotic Cardiovascular Disease","enrollment":2382},{"nctId":"NCT04251364","phase":"NA","title":"Treatment of Chronic Mountain Sickness","status":"COMPLETED","sponsor":"Centre d'Expertise sur l'Altitude EXALT","startDate":"2020-02-15","conditions":"Hypoxia, Altitude","enrollment":60},{"nctId":"NCT07088250","phase":"NA","title":"Statins for Treatment of Primary Intracerebral Hemorrhage","status":"RECRUITING","sponsor":"The Second Hospital of Anhui Medical University","startDate":"2023-05-06","conditions":"Cerebrovascular Disorders, Intracranial Hemorrhages, Intracranial Hemorrhage","enrollment":264},{"nctId":"NCT07084259","phase":"PHASE4","title":"Single Dose PCSK9 Inhibitor to Improve Cardiovascular Outcomes After PCI: A Pilot Study","status":"NOT_YET_RECRUITING","sponsor":"Hanyang University Seoul Hospital","startDate":"2025-07","conditions":"Coronary Artery Disease","enrollment":352},{"nctId":"NCT06647238","phase":"NA","title":"Evaluation of Pharmacist Interventions in Lipid Management for Secondary Prevention","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2024-11-05","conditions":"Hyperlipidemia, Coronary Artery Disease","enrollment":80},{"nctId":"NCT03896217","phase":"PHASE2","title":"Simvastatin in Secondary Progressive Multiple Sclerosis","status":"COMPLETED","sponsor":"University College, London","startDate":"2019-05-16","conditions":"Secondary Progressive Multiple Sclerosis","enrollment":40},{"nctId":"NCT06930092","phase":"NA","title":"RestoratIon of Myocardial Function by PeRcutaneous cOronary interVEntion in Patients With Ischemic CardioMyoPathy","status":"RECRUITING","sponsor":"Seoul National University Hospital","startDate":"2025-07-01","conditions":"Ischemic Cardiomyopathy","enrollment":158},{"nctId":"NCT06101667","phase":"NA","title":"Efficacy and Safety of Endovascular Recanalization for Acute Basilar Artery Occlusion With Extended Time Window (ANGEL-BAO)","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2023-10-15","conditions":"Acute Ischemic Stroke, Basilar Artery Occlusion","enrollment":224},{"nctId":"NCT06789588","phase":"PHASE3","title":"Protocol for Improvement of Therapy With Warfarin","status":"ENROLLING_BY_INVITATION","sponsor":"University of Pernambuco","startDate":"2024-10-21","conditions":"Atrial Fibrillation (AF)","enrollment":700},{"nctId":"NCT06996223","phase":"EARLY_PHASE1","title":"A Multicenter, Prospective, Randomized Controlled Trial to Evaluate the Efficacy of PCSK-9 Inhibitors in Delaying the Progression of Calcified Aortic Valve Disease","status":"NOT_YET_RECRUITING","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2025-06-01","conditions":"Aortic Stenosis, PCSK9 Inhibitor, Calcified Aortic Valve Disease","enrollment":316},{"nctId":"NCT05586750","phase":"PHASE4","title":"Statins in Reducing Events in the Elderly Mind (STAREE-Mind) Imaging Substudy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Monash University","startDate":"2019-09-19","conditions":"Dementia, Mixed, Dementia, Vascular, Dementia of Alzheimer Type","enrollment":341},{"nctId":"NCT06649240","phase":"NA","title":"Optimal Target Low-density Lipoprotein Cholesterol Level for Small Vessel Occlusion Stroke","status":"RECRUITING","sponsor":"Seoul National University Hospital","startDate":"2024-10-04","conditions":"Ischemic Stroke, Small Vessel Cerebrovascular Disease, Cholesterol, LDL","enrollment":4016},{"nctId":"NCT06695429","phase":"NA","title":"Supplementation With Beetroot Juice to Prevent Contrast Associated Nephropathy During Hospitalization for Acute Coronary Syndrome Without ST Elevation","status":"RECRUITING","sponsor":"Hospital General Universitario Santa Lucia","startDate":"2024-10-07","conditions":"Non ST Segment Elevation Acute Coronary Syndrome, Contrast Induced Nephropathy","enrollment":130},{"nctId":"NCT02943590","phase":"PHASE2","title":"STOP-CA (Statins TO Prevent the Cardiotoxicity From Anthracyclines)","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2017-01-13","conditions":"Heart Failure","enrollment":300},{"nctId":"NCT03110432","phase":"","title":"Prospective German Very High Cardiovascular Risk Patients Dyslipidemia Treatment Indication Registry","status":"COMPLETED","sponsor":"GWT-TUD GmbH","startDate":"2017-05-18","conditions":"Dyslipoproteinemias, Hypercholesterolemia, Familial, Familial Hypercholesterolemia - Homozygous","enrollment":1695}],"_emaApprovals":[],"_faersSignals":[{"count":6,"reaction":"HYPERTENSION"},{"count":5,"reaction":"MYOCARDIAL INFARCTION"},{"count":4,"reaction":"BLOOD CHOLESTEROL INCREASED"},{"count":4,"reaction":"MYALGIA"},{"count":3,"reaction":"DIZZINESS"},{"count":3,"reaction":"DRUG INEFFECTIVE"},{"count":3,"reaction":"PAIN"},{"count":2,"reaction":"ABNORMAL BEHAVIOUR"},{"count":2,"reaction":"DIABETES MELLITUS"},{"count":2,"reaction":"FATIGUE"}],"_approvalHistory":[],"publicationCount":128,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Statins, HMG CoA","genericName":"Statins, HMG CoA","companyName":"National Heart, Lung, and Blood Institute (NHLBI)","companyId":"national-heart-lung-and-blood-institute-nhlbi","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Statins are a class of small molecule drugs that lower cholesterol levels in the blood, primarily used to treat conditions such as hypercholesterolemia, coronary heart disease, and diastolic dysfunction. They work by inhibiting the enzyme HMG-CoA reductase, which is involved in the production of cholesterol in the liver.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}